mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.003 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.003 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |